Reboxetine

Reboxetine

Reboxetine (/rɪˈbɒksɪtiːn/) is a norepinephrine (noradrenaline) reuptake inhibitor used in the treatment of depression, panic disorders and ADHD.

Etymology

The term "Reboxetine" is derived from the systematic (IUPAC) name: 2-[(2-ethoxyphenoxy)benzyl]morpholine. The drug was first approved for use in the United Kingdom in 1997.

Usage

Reboxetine is used primarily in the treatment of depression. It is also used off-label in the treatment of panic disorders and ADHD. It works by inhibiting the reuptake of norepinephrine, thereby increasing the amount of norepinephrine in the brain.

Side Effects

Common side effects of Reboxetine include dry mouth, constipation, sweating, insomnia, and vertigo. More serious side effects may include heart problems, liver problems, and severe allergic reactions.

Related Terms

• Norepinephrine reuptake inhibitor
• Depression
• Panic disorder
• Attention deficit hyperactivity disorder
• Side effect

See Also

• List of antidepressants
• List of psychiatric medications by condition treated

External links

• Medical encyclopedia article on Reboxetine
• Wikipedia's article - Reboxetine

This WikiMD article is a stub. You can help make it a full article.

---

Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski